Literature DB >> 12829282

Characterization of RAP, a quorum sensing activator of Staphylococcus aureus.

Moshe Korem1, Abhineet S Sheoran, Yael Gov, Saul Tzipori, Ilya Borovok, Naomi Balaban.   

Abstract

Staphylococcus aureus are Gram-positive bacteria and cause diverse serious diseases in humans and animals through the production of toxins. The production of toxins is regulated by quorum sensing mechanisms, where proteins such as RNAIII activating protein (RAP) are secreted by the bacteria and induce virulence. Antibodies to RAP have been shown to protect mice from infection, but the molecular structure of RAP was not known and hindered vaccine development. To characterize RAP, recombinant protein was made and tested for its ability to induce genes important for pathogenesis (agr). In addition, monoclonal antibodies were produced to identify its cellular localization. Results shown here indicate that RAP is a 277-aa protein that is an ortholog of the ribosomal protein L2. Like the native molecule, recombinant RAP activates the production of RNAIII (encoded by agr). Using RAP specific monoclonal antibodies we demonstrate that RAP is continuously secreted and while RAP is expressed also in other bacteria (like Staphylococcus epidermidis, Staphylococcus xylosus and Escherichia coli), it is secreted to the culture medium only by S. aureus. Our results show that the ribosomal protein L2 has an extraribosomal function and that when secreted RAP acts as an autoinducer of virulence to regulate S. aureus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829282     DOI: 10.1016/S0378-1097(03)00326-4

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  12 in total

1.  Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence.

Authors:  Moshe Korem; Yael Gov; Madanahally D Kiran; Naomi Balaban
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 2.  Engineering approaches for the detection and control of orthopaedic biofilm infections.

Authors:  Garth D Ehrlich; Paul Stoodley; Sandeep Kathju; Yongjun Zhao; Bruce R McLeod; Naomi Balaban; Fen Ze Hu; Nicholas G Sotereanos; J William Costerton; Philip S Stewart; J Christopher Post; Qiao Lin
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

3.  Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP.

Authors:  Naomi Balaban; Oscar Cirioni; Andrea Giacometti; Roberto Ghiselli; Joel B Braunstein; Carmela Silvestri; Federico Mocchegiani; Vittorio Saba; Giorgio Scalise
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation.

Authors:  Laura H Tsang; Sonja T Daily; Elizabeth C Weiss; Mark S Smeltzer
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

5.  A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan.

Authors:  Rajan P Adhikari; Staffan Arvidson; Richard P Novick
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

6.  A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis.

Authors:  Peter J McNamara; Arnold S Bayer
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: new role for the NADPH oxidase in host defense.

Authors:  Jacob M Rothfork; Graham S Timmins; Michael N Harris; Xian Chen; Aldons J Lusis; Michael Otto; Ambrose L Cheung; Hattie D Gresham
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

8.  Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.

Authors:  Roderick A MacPhee; Wayne L Miller; Gregory B Gloor; John K McCormick; Jo-Anne Hammond; Jeremy P Burton; Gregor Reid
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

9.  Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus.

Authors:  Lindsey N Shaw; Ing-Marie Jonsson; Vineet K Singh; Andrej Tarkowski; George C Stewart
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

10.  Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective.

Authors:  Christopher P Gordon; Paul Williams; Weng C Chan
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.